Semantic Scholar uses AI to extract papers important to this topic.
ObjectivesTo develop a recombinant human factor IX (rFIX) formulation equivalent to commercially available products in terms of… Expand Dear Sir, Factor VIII and IX products with enhanced half-life are being introduced into routine clinical practice1. Not… Expand FIX binds tightly to collagen IV. Furthermore, a FIX mutant, FIXK5R, which binds better than wild-type FIX to collagen IV… Expand Recombinant clotting factors are important biotherapeutics that Pfizer has produced and marketed for over fifteen years. Owing to… Expand Due to variability in the one-stage clotting assay, the performance of new factor IX (FIX) products should be assessed in this… Expand Head‐on comparative studies of factor IX (FIX) concentrates performed under standardized conditions are rarely conducted… Expand Abstract 2266 Recombinant Factor IX Fc fusion (rFIXFc) was designed to be a long-lasting version of recombinant FIX that has the… Expand Summary. BeneFix®, the only recombinant factor IX (FIX), has been reformulated. The reformulation involves a change in diluent… Expand The safety and efficacy of adjusted continuous infusion (CI) of recombinant factor IX (FIX; BeneFix®) was assessed in vitro and… Expand The effects of a recombinant factor IX product (BeneFix), and of five plasma‐derived factor IX products, AlphaNine, Immunine… Expand